Danxia Q. Zheng
49 Huayuan North Road
Huayuan, 100191, China
Huayuan, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Diagnostic performance of time-resolved fluoroimmunoassay based anti-phospholipase A2 receptor antibody detection for primary membranous nephropathy.
Journal: Scientific reports
Published: February 13, 2026
Obinutuzumab alone may be an effective option for adult minimal change disease: a single-center retrospective observational study.
Journal: BMC nephrology
Published: November 26, 2025
Rare case report: a man with rheumatoid arthritis developed membranous nephropathy and ANCA-associated vasculitis successively.
Journal: BMC nephrology
Published: July 29, 2025
Development and application of an ultrasensitive immunoassay for antiphospholipase A2 receptor antibodies in the differential diagnosis of membranous nephropathy.
Journal: Analytical methods : advancing methods and applications
Published: June 23, 2025
Time-resolved fluoroimmunoassay improves sensitivity in the diagnosis of primary membranous nephropathy with low phospholipase A2 receptor antibody titer.
Journal: Scientific reports
Published: April 29, 2025
Anti-PLA2R IgG4-to-IgG Ratio Helps Predict Remission of PLA2R-Associated Primary Membranous Nephropathy.
Journal: American journal of nephrology
Published: April 28, 2025
The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: a single-center retrospective study in China.
Journal: Renal failure
Published: September 19, 2023
Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study.
Journal: Frontiers in pharmacology
Published: April 03, 2023
Use of low-protein staple foods in the dietary management of patients with stage 3-4 chronic kidney disease: a prospective case-crossover study.
Journal: BMC nephrology
Published: August 23, 2021
Last Updated: 09/26/2026